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Abstract
Purpose Bladder cancer (BC) is a common disease with dis-
parate treatment options and variable outcomes. Despite the
disease’s high prevalence, little is known of the lived experi-
ence of affected patients. National patient experience surveys
suggest that those with BC have poorer experiences than those
with other common cancers. The aim of this review is to
identify first-hand accounts of the lived experiences of diag-
nosis through to survivorship.
Method This is a systematic review of the qualitative evidence
reporting first-hand accounts of the experiences of being di-
agnosed with, treated for and surviving bladder cancer. A
thematic analysis and ‘best-fit’ framework synthesis was un-
dertaken to classify these experiences.
Results The inconsistent nature of symptoms contributes to
delays in diagnosis. Post-diagnosis, many patients are not ac-
tively engaged in the treatment decision-making process and
rely on their doctor’s expertise. This can result in patients not
adequately exploring the consequences of these decisions.
Learning how to cope with a ‘post-surgery body’, changing
sexuality and incontinence are distressing. Much less is
known about the quality of life of patients receiving conser-
vative treatments such as Bacillus Calmette-Guerin (BCG).
Conclusions The review contributes to a greater understand-
ing of the lived experience of bladder cancer. Findings reflect
a paucity of relevant literature and a need to develop more
sensitive patient-reported outcome measures (PROMs) and
incorporate patient-reported outcomes in BC care pathways.
Implications for cancer survivors Collective knowledge of
the patients’ self-reported experience of the cancer care path-
way will facilitate understanding of the outcomes following
treatment.
Keywords Bladder cancer . Diagnosis . Treatment .
Cystectomy . Quality of life . Patients’ experience
Introduction
Bladder cancer (BC) is the seventh most common cancer in
the world [1] and is one of the most expensive to manage [2].
The disease is more common in males than females, reflecting
the main etiological risk factors, i.e. cigarette smoking and
occupational carcinogen exposure [3]. Despite advances in
the epidemiology and treatment, relatively little is known
about the experience of patients diagnosed with BC [4, 5].
Patient surveys have shown that the experience of those with
BC is one of the poorest when compared to other cancers.
Potential explanations for this include absence of care plan-
ning, emotional support and poor post-discharge care [6].
These factors may be compounded by the male predominance
of BC and the tendency of men to internalise their illness
behaviour [7].
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Whilst most cancers affect the well-being and quality of life
(QoL) of diagnosed individuals and their caregivers, the QoL
for BC patients is not well known due to a lack of disease and
treatment-specific validated measure(s) and a lack of large-
scale analyses [8–13]. Where data are available, reports are
often restricted to small samples post-treatment [14, 15] and
so limit the understanding of the BC patients’ experience fol-
lowing diagnosis and pre-treatment experience of care
(reviewed in [4]). Developing new measures which identify
care needs across the patients’ pathway will help improve
clinical practice and assist them in the early stages of their
diagnosis and treatment decision making [16]. Given that re-
cent reviews have focussed upon quantitative data (e.g. [4]),
we undertook a systematic review of the current status of
qualitative data in patients with BC.
In 2010, the National Cancer Survivor Initiative (NCSI)
published a ‘vision’ document [5] that reported a number of
key shifts required in the approach to care for people living
with and beyond cancer. One key vision wasmoving the focus
from measuring clinical activity to measuring experience,
concerns and outcomes for cancer survivors through routine
use of patient-reported outcome measures (PROMs). The val-
ue of qualitative research in the development of PRO mea-
sures has been recognised for some time. For example,
Duncan et al. [17] recently conducted a synthesis of the
qualitative evidence to examine the QoL domains from the
patients’ perspective to facilitate PROM development in five
specific health conditions. This article also presents a system-
atic search of the qualitative literature and a ‘best-fit’ frame-
work synthesis [18] to classify and enhance the understanding
of the experiences of BC from the patients’ perspective.
Findings may also assist future PROM development.
Method
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines were followed, including ref-
erence to the 27-item checklist (where applicable) and four-
phase item flow diagram [19] (see Fig. 1).
Literature search
Medline, PsycInfo, Embase, CINAHL, Cochrane Library,
Global Health, Scopus, Pro Quest (Health & Medicine) and
Google Scholar were searched for articles published between
January 2000 and January 2016. A combination of keywords
to describe the patient, patients’ experience, BC, treatment and
researchmethod was used (for example, to describe the patient
[patient, cancer patient, surgical patient, hospitalised patient],
Studies included in final review  
= 14 
Citations from title review = 242 
 Excluded at title review = 1929 
Duplicates 27) & those unrelated to bladder 
cancer (1902) 
Citations from abstract review = 50 
Excluded at abstract review = 192 
Records excluded at full article review = 36 
Cancer type not reported = 10 
Bladder cancer not included = 10 
Not a primary study (reviews) or Qualitative = 6 
Focus of paper not specific to BC treatment = 1 
Unable to extract BC related themes = 4 
Unable to access full results = 2 (unpublished, 
conference abstract only) 
Not English = 1 
Sample N/A (BC not primary cancer) = 1  
Hypothetical = 1 
Citation from database search = 
2151 
Citations from other sources = 47 
Total = 2198 
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 Fig. 1 Flow chart of included
and excluded studies
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their experience [acceptance, attitude, beliefs, opinion, satis-
faction, QoL, quality of care, understanding, feelings], the
cancer [BC, urinary bladder neoplasms, bladder, carcinoma],
the treatment [intravesical immunotherapy, BCG vaccine,
cystectomy, surgery] and the research method [interview, case
studies, observations, focus group, thematic analysis], see on-
line resource 1 for sample search strategy). In addition, refer-
ence lists and citations of included studies were scanned and
specific urology journals were hand searched (Current
Opinion in Urology, European Urology, Urology Practice,
Journal of Urology, Urology, Scandinavian Journal of
Urology and Nephrology and Scandinavian Journal of
Urology and Asian Journal of Urology). Lead authors (iden-
tified from the searches/included studies) and conference ab-
stracts (APOS, BPOS) were searched. English language re-
striction was applied to the search.
Study selection
All primary studies detailing self-reported accounts of the ex-
perience of being diagnosed and treated for BC (primary can-
cer) were included in the review, meaning that results are
based upon the narratives of individuals with BC. Studies that
reported survey data only or hypothetical data were excluded.
Two authors (AE and JB) reviewed the titles and abstracts to
apply the inclusion criteria, and potentially eligible full-text
articles were evaluated by AE, JB and MT for eligibility and
quality. Each article was assessed for quality using the Critical
Appraisal Skills Programme (CASP) assessment tool for qual-
itative research [20]. All studies were included in the review
regardless of their quality rating, but the rating was used as an
indication of the strength of the evidence and to inform stan-
dards required for future research into the qualitative experi-
ences of people diagnosed with BC. Disagreements were re-
solved by discussion.
Data synthesis
Data regarding population, age range, participant numbers,
diagnosis, treatment, data collection approach and derived
themes were extracted using a standardised form. A thematic
analysis of all the identified lived experiences of BC, using a
‘best-fit framework synthesis’ [18], was undertaken starting
with very similar themes to those described by Beitz and
Zuzelo [21], which were experience of diagnosis, acute care
and treatment, post-treatment and the new normal. These in-
formed the framework as they encompassed the patients’ path-
way from diagnosis to survivorship and adapting (or not) to
life and thereby fit with the aims of this review. Initial alloca-
tion of experiences to the framework was undertaken by AE
aided by discussion with JB and MT in uncertain cases.
Results
Manuscript selection
In total, 2198 manuscripts were identified, from which 14
eligible studies were selected (Fig. 1 and online resource 2).
Most studies were North American (n = 9) or British (n = 3),
with 1 from Italy and Sweden. Accounts of 270 participants,
of which 188 (70%) were male and 76 (30%) were female
(gender missing in one study, n = 6), with an age range from
33 to 86 years are reported. Diagnoses included non-muscle-
invasive, muscle-invasive and metastatic BC. Treatments in-
cluded radical cystectomy with various urinary diversions,
systemic chemotherapy, radical radiation, transurethral resec-
tion and intravesical Bacillus Calmette-Guerin (BCG). At
least half of the studies focus on the experiences of radical
surgery patients, other papers did not report treatments pro-
vided, and only two papers focussed exclusively on BCG
patients. Articles were scored for quality, with a mean quality
score of 7 (range 5–9/9 points). Lower scores reflected an
absence of ethical standard statements and risk or presence
of bias during the process.
Patients’ experience of diagnosis
Patients’ experience of diagnosis theme captures patients’ re-
ported experience of being diagnosed with BC, including pre-
senting symptoms, diagnostic process, pre-treatment consul-
tations and the treatment decision-making process.
Diagnosing BC
Typical symptoms of BC were visible haematuria and altered
urination patterns (urgency, frequency and dysuria) [21, 22].
Patients described haematuria as deceptive due to its painless
and inconsistent nature [21]. The lack of pain and understand-
ing about BC led to a delay in seeking help [21, 23, 24].When
help was sought, some felt frustrated that their symptomswere
trivialised and misdiagnosed. For example, women presenting
with blood in their urine were often met with ‘are you sure it’s
not just your menstrual cycle?’ [21], reflecting the typical
delay in referral for female patients with BC [25].
A typical response to diagnosis was shock, upset [21, 23]
and devastation [26], followed by a fear of treatment [26] and
an intense desire for a speedy intervention [21]. Some de-
scribed feeling ‘scared to death’ and thought of their diagnosis
as a death sentence [21, 23, 26]: ‘you’re sitting there thinking
I’m going to die’ [23]. Hilton and Henderson [24] described
this experience as ‘unknowing’—everything that patients
know about their health is suddenly called into question and
they may now worry that their overall health will deteriorate
[26].
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Treatment decision making
Making treatment decisions was perceived as very challenging.
Patients described difficulty understanding medical explana-
tions, treatment options and potential side effects [27] and felt
uncomfortable making such decisions [21]. Cancer information
became important, and patients reported receiving insufficient
information about self-care after treatment (surgery), finances
and insurance, and subsequently, many sought information via
the internet and/or support groups [27]. Worries about survival,
pain, reduced sexual function and change in body image (after
surgery) were often not addressed. In one recent study, only 6
out of 30 patients reported discussing likely changes in sexual
function following surgery during the treatment consultation
[27]. Some patients also reported receiving conflicting treat-
ment recommendations and felt that there was a bias towards
particular treatments depending on the healthcare professional
that they spoke to [21].
Berry and colleagues [28] explored how patients perceived
and engaged in treatment decision making. They found pa-
tients expended significant effort in identifying the best
healthcare provider ‘one of the things I’ve always kept as a
reference point is where are the centers of excellence for var-
ious treatments?’ [28], even if this meant travelling a signifi-
cant distance for treatment. In contrast, when considering
treatment choice, almost half of patients were passive in the
decision-making process and accepted the clinicians’ treat-
ment recommendation without question, but this was not con-
structed as problematic by patients ‘it’s like, no you [clinician]
tell me what to do’ [28] and was most common in patients
with early-stage disease. Other patients sought information
from the internet, family, friends and others with knowledge/
personal experience to inform discussions with their clinician.
A small number reported having complete control over the
decision ‘at the end I [patient] was the only one who would
make the decision’ [28]. Treatment choice was largely influ-
enced by survival statistics, but other factors, such as treat-
ment preferences [29], age and level of recreational and work
activity, played an important role [28]: ‘I based it on the fact
I’m 59 so it’s not like I’m 20 and I have to live with this bag
for a hundred years’; ‘I’ve never had a period in my life where
I wasn’t exercising so an ostomy bag was really not an option
for me’ [28].
Unsurprisingly, open communication was a critical and
reoccurring theme throughout the patients’ pathway, but par-
ticularly so in diagnosis and treatment consultations [23, 28,
30]. Early impressions of interpersonal aspects of patient care
are important to the patient, in particular whether they feel that
they are being treated as someone who matters and is worthy
of care and being recognised and responded to as a unique
individual with a particular social context [30]—‘I say yes it’s
like being on first name terms with some of them…oh they get
to know you and you get to know them’ [30]. Patients
believed that it was important to have ‘a conversation’ with
the clinician, where the options are discussed to ensure that the
clinician understands the impact of treatment options on the
patient’s life. The speed and momentum of diagnosis and
treatment can result in patients feeling ill prepared, in partic-
ular for the side effects of treatment [28]. They wanted treat-
ment plans to be clear, provided in a timely fashion and con-
sistent from professional to professional [23].
Patients’ experience of acute care and treatment
Patients’ experience of acute care and treatment theme cap-
tures patients’ experiences of preparing for treatment and their
acute care.
Preparing for surgery
The psychological preparation for surgery can start weeks
before admission [24, 31]. One patient described it as worse
than the diagnosis; for her, the thought of the impending sur-
gical procedure (vaginal reconstruction) was devastating and
terrifying, and she felt uncertain whether she would ever be
the same again [24]. Hilton and Henderson [24] described this
experience of an impending bodily change as ‘metamorpho-
sis’. Physical pre-surgical procedures were also captured in
detail. For example, patients recalled the onerous procedures
of bowel preparation prior to surgery [21], and neobladder
reconstruction patients recalled being measured and ‘tattooed’
for stoma placement prior to their surgery, even though they
were not expecting a stoma. This was described as unsettling,
and for some, the fear of the change to self following surgery
felt worse than the diagnosis [21, 24].
Waking up after surgery
Waking after surgery is described as a feeling of ‘alienation
from the body’ [32]. This encapsulates the shock and disgust
some patients’ experience in response to their stoma and nu-
merous abdominal drains [21]. Simple acts of kindness are
important ‘what a nice woman that was [nurse] when I woke
up after my first operation when I opened my eyes she was
sitting at my bed holding my hand now what do you think of
that…that’s a good one’ [30].
Post-operative care
Hands-on training on patient’ stoma appliances and catheters
begins in the acute recovery phase. This was a positive expe-
rience, but many felt that it should have continued after dis-
charge [27]. Although aftercare was generally good, for some,
post-operative pain was not well managed, with pain manage-
ment regimes leaving patients feeling ‘knocked out’ or
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‘mentally in the left field’ [21] and disorientated to time and
place [21].
Patients’ experience of non-radical surgical treatment
Two studies captured non-radical surgical treatment experi-
ences. Patients commonly reported short-lived related symp-
toms [22, 26]. Patients receiving BCG treatment reported ab-
dominal pain and painful, urgent and more frequent urination
[22]. Some also reported passing blood clots and blood in the
urine, flu-like symptoms, fatigue and soreness at the catheter
site [22]. Clark [22] interviewed patients who had undergone
TURBT, and those patients described painful and urgent uri-
nation, knife-like stinging and passing blood clots—‘it was
just the initial shock when you put that thing in, and the first
time you go to the potty and urinate that hurt. That hurt like
hell’. However, symptoms were generally temporary.
Patients’ experience post-treatment
Patients’ experience post-treatment theme mostly captures the
period shortly after treatment, during which patients experi-
ence immense change, and details the ways in which people
learn to adapt to new, often distressing experiences.
Post-surgery recuperation was long and something that pa-
tients felt that they needed support with [21]. It was described
by one patient as ‘the point I became a cancer survivor’ [24].
Hilton and Henderson [24] referred to this experience as ‘an
unfolding path’—recuperation was a time of immense change,
encompassing new experiences, new learning and adaptation
both physically and psychologically [21, 23, 24]. Weight loss
following surgery was common, and patients felt exhausted
and weak on their return home. Although they felt unhappy
about lost vitality, there was a sense of acceptance that they
needed to pace their activities and some employed coping strat-
egies, such as starting walking routines to regain strength [21].
Support of family and friends was especially valuable at
this time, though paradoxically, this was a time when some
experienced disappointment and difficulty with close relation-
ships; a few patients reported feeling disappointed by the lack
of support and felt as though they were being treated differ-
ently [23].
Patients’ experience of homecare was variable, and it was a
lottery in terms of howmuch aftercare theymight receive [23].
Knowledge and expertise to deliver homecare to patients fol-
lowing a radical cystectomy varied—‘the homecare, nobody,
not one person knew or had any experience with this. They
had experience with bowels but not bladder’ [23].
New experiences were often unexpected and distressing.
For example, patients reported not being told how they could
deal with incontinence. Many reported initiating their own
strategies such as wearing pads at night, changing underwear
style, only wearing black trousers so leakage would not show
and establishing bladder schedules, for example, setting
alarms to go off through the night to ensure regular voiding
[21, 23], in the absence of education from healthcare services
[23]. Some neobladder patients had to learn to self-catheterise;
this felt easier than learning to void their neobladder. The
mechanics of voiding the neobladder are very different to
those of their original bladder and more redolent of defecation
in that they needed to ‘force it out’ and ‘strain’ [21]. Self-
catheterising for some, however, felt disgusting and was
avoided [21].
The new normal
Having experienced a period of immense change, this theme
captures the next phase, referred to as the ‘new normal’ [21].
Here, patients describe their QoL post-treatment, i.e. their ex-
perience of adapting (or not) to new toileting characteristics,
newways of being sexual and living with the lifelong threat of
cancer.
Quality of life (QoL) following treatment for BC was
mixed for both surgical and non-surgical patients. Patients
reported both negative and positive aspects, but they were also
something fluid and they fluctuated over time [15, 29]. For
example, Cerruto and colleagues [15] explored the QoL of a
cross section of patients (1 year post-surgery up to 30 years)
who had an ileal conduit following a radical cystectomy. They
presented patient profiles at 1, 3, 5, 7 and plus 7 years post-
surgery. One year post-surgery, QoL was reported to be good/
unchanged for some, but for others, it was worse, with poor
sleep and being dependent on others to manage their ostomy
notable areas of concern. By 3 years, most reported having
poor QoL; main areas of difficulty were continued depen-
dence on partners to manage their ostomy, concern about
leakage and smell of urine and subsequent decline of social
activities. Worsening of QoL over time was reported for
surgical and non-surgical populations and attributed to a
decreasing optimism about recovery [15, 29] and for surgical
patients, the overwhelming feeling of not being the same [15].
Loss of friendships and the detrimental impact on social life
were also reported by Persson and Hellstrom [32], but they
noted that these occurred quite soon after surgery when
patients were faced with who, how to tell and how people
would react.
By 5 years post-treatment, QoL had improved and patients
reported feeling in a better state of health compared to pre-
surgery. Cerruto and colleagues [15] attributed this improve-
ment to adaptation. Patients reported feeling less dependent on
partners; problems such as urinary leakage remained, but
these were managed; ‘I don’t have anxiety about my condi-
tion, there are some precautions that should be observed, I
must be careful that there are no leaks but it happens rarely
in my case and I can live almost normally’ [15]. By 7 years
post-surgery, social relations had recovered and activities of
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daily living felt less restricted. This finding was also supported
by Foley et al. [33] who explored the cancer experience of
long-term survivors and found over time that survivors had
acquired a greater appreciation for life.
However, some concerns persisted over time; for surgical
patients, this included a lack of sexual activity and physical
complications such as hernias, urinary tract infections and
peristomal skin lesions, which affect ostomy management
and risk leakage [15]. Long-term effects of cancer were de-
scribed by survivors as ‘a constant’ in their lives and as a
reminder of their cancer [21, 34].
Accepting incontinence
Incontinence following surgery was generally permanent, and
learning not to be embarrassed about leakage was key to suc-
cessful management [21]. New routines to respond to new
toileting characteristics were commonplace [21, 27]. Some
patients described difficulties and subsequent adaptations re-
lated to returning to work. For example, finding a clean place
to self-catheterise away from home was described as difficult,
particularly for men. Male public toilets were often perceived
as dirty, and sitting on the toilet seat was unfamiliar and frus-
trating. For some men, this resulted in a reluctance to travel or
where necessary holding large volumes of urine to avoid using
public toilets. For some, a change in toilet characteristics also
extended to their bowels; some experienced chronic diarrhoea
and unpredictable flatulence [21, 32]. Patients described locat-
ing toilets ahead of time as a protective strategy, and planning
their toilet use became a major priority [21, 27]: ‘If you go to
some function probably the first thing you seek out is the
toilet’; ‘Life is normal. It’s almost as if it didn’t happen except
for the inconvenience of having to sit and plan where I go
based on having to go to the bathroom’ [21].
Despite understanding the importance of hydration, many
surgical participants reported not drinking enough. For some,
this was because of the need to subsequently empty their blad-
der, which meant staying closer to a toilet, which increased
isolation as patients remained at home; for others, it was about
managing continence, with some patients avoiding beer as this
often resulted in night-time leakage [21].
Ongoing fears included leakage of gas and odour and visibil-
ity of the stoma [32]. Patients often selected different clothes to
minimise visibility and damage to the stoma (e.g. wearing loose
dresses, supporting the stoma with suspenders [32]). Concerns
about visibility also resulted in changes to social activities, for
example, avoidance of swimming pools [32].
Changing sexuality
Changes in sexuality were reported by men and women [27]
who had undergone non-surgical [26, 35] and radical surgical
treatment [21, 23, 35]. Non-radically treated patients usually
reported a short period of abstinence due to fear of contami-
nation of their partner with the treating agents [26, 35], but for
some, abstinence seemed more permanent ‘we don’t have sex
because of that stuff they were putting in me. I still get an
erection and masturbate and I don’t tell her about that but I
do and when I come it doesn’t come out like it used to because
of that irritation in there’ [35]. For radical surgical patients,
despite having prior knowledge about the impact on sexual
function, i.e. impotence for men and vaginal shortening/
dryness for women, the reality was still a shock. Men in par-
ticular had been certain that it would not be the case for them
and described impotence as a loss of their manhood, which led
to other ways of achieving an erection [27, 35], but this was
often met with disappointment [21]; ‘no more sex life, I feel
destroyed physically, emotionally. Once I was a master of
myself, now I depend on my wife. The surgery carried away
all that I had’ [15]. For others, sexual relationships were re-
established but in a different way; ‘BC has changed our sex
life a bit, we still have sex but it’s different now, well obvi-
ously it’s different for me. Since I can’t have normal inter-
course it’s a lot of foreplay but I enjoy that too. It’s not as good
as it was before but it’s still pretty good, I bought a vibrator so
she can still have orgasms—it changed the dynamic of sex,
you know it’s more to make sure she has an orgasm’ [35].
Post-surgery, women reported physical and psychological
concerns about sex [23, 27, 35], with the loss of physical
intimacy commonly reported ‘sometimes it’s almost a platonic
relationship’ [35]. The appearance of the stoma and the bag
were of concern for some as they perceived it to be off-putting
sexually [23, 27, 32, 35], with some fearing leakage from the
stoma during sex [23]; ‘not in a million years would I let
anybody close to me with this stoma and bag and all that,
I’m disgusting. How it looks, I mean I have a bag of pee
hanging in front of me, I find it revolting I’m sure anyone else
would’ [23].
The degree of acceptance about loss of sexual function was
reported to be influenced by age, stage of life and how much
importance a couple placed on sex [23]. In contrast, re-
establishing a sexual relationship after BC was influenced by
good communication between partners [35]. Interestingly, de-
spite how common sexual problems seem to be amongst BC
survivors, very few sought professional assistance [27], with
Mohamed and colleagues positing that this was perhaps due to
the fact that many were grateful to be alive [27].
Living with the lifelong threat of cancer
‘Deal with it’ and ‘just take it as it comes’ attitudes were
commonplace [21, 29, 33, 34]. Survivors reported being very
aware that many people die from BC, and so, a stoical and
optimistic attitude to new experiences soon developed [21, 23,
33]. Similarly, living each day and having a new found sense
of appreciation for their life were also apparent and may be
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partly attributed to the perception of cancer as a lifelong threat
[21, 27, 34]. Follow-up schedules proved to be a constant
reminder of how fragile life can be [21, 34], and many survi-
vors reported that support from family and friends had been
vital throughout their journey with cancer [29, 34] (see online
resource 3 for a preliminary conceptual framework of the pa-
tients’ experience of being diagnosed with BC through to
survivorship).
Discussion
This is the first systematic review of qualitative evidence fo-
cusing upon first-hand accounts of the lived experience of BC.
The review identified the significant impact of this disease
upon the patient and their next of kin and that currently, there
is little attention paid to this by BC care practitioners. Most of
the data reported events at the beginning (at diagnosis) and
end (life after treatment) of the patients’ pathway, and there
was an over-representation of patients undergoing radical sur-
gery, when the majority of patients receive non-radical
(conservative) treatments. As the concerns of those undergo-
ing conservative treatments cannot be assumed to be the same
as those of the RC population, the review highlights the need
for more qualitative research to inform understanding of the
experiences of this population.
Sexual concerns were especially common with an unmet
need for information and support [21, 23, 26, 27, 32, 35],
which support the findings of a recent PROM pilot report
[36]. The fact that very few patients reported receiving help
for sexual distress is a concern [27] and suggests perhaps that
the shift towards exploring the patients’ holistic experience, in
particular their sexual experience, as set out by the National
Cancer Survivorship vision has not yet been reached [5]. The
findings of the review suggest that health professionals need
to be more proactive in eliciting areas of distress and, given
the gender-specific concerns highlighted in this review, tai-
lored interventions would be more appropriate [27].
Body image was an important concern for those undergoing
surgery. Patients reported experiencing significant alteration to
their body [32], and women in particular reported feeling unsex-
ual [23, 27, 32, 35]. Visibility of the stoma was problematic and
resulted in patients altering clothing and social activities [32].
Concerns about body image were also reported in the PROM
pilot report, and the findings of this review evidence that conclu-
sion [36]. Only one (excluded) study found body image not to be
important [37], but this may be due to those authors asking
patients to consider a future event (impact of surgery) on body
image; it is not clear whether patients were specifically asked
about appearance post-surgery, and given the duration of the
interviews (16 min on average), it seems unlikely that any dis-
cussion would have been in-depth. Encouraging patients to re-
flect on their experiences in some depth enables a more valid
disclosure of concerns [32], which might account for the dispa-
rate findings.
Less frequently described but nonetheless explored was
patients’ experience of acute care and discharge, and this re-
view highlights how some of the most basic acts of kindness,
such as holding a patient’s hand on waking from surgery, can
make such a difference to their experience.
This review identifies a relatively neglected area of cancer
and the poor level of evidence in this field. It offers an under-
standing of the patients’ experience pre-diagnosis through to
survivorship, complementing a recent BC PROM pilot [36]
and ongoing work in BC QoL development to develop ways
to comprehensively assess sexual [8] and body image issues in
particular [38]. It also serves as a useful starting point for
developing teaching/training materials. Knowledge of the pa-
tients’ experience from diagnosis through to survivorship and
highlighting the challenges in reporting concerns are valuable
to new and existing health professionals tasked with shifting
the focus from clinical activity to patients’ experience. Finally,
it is a response to patients’ hopes for professionals to better
understand their experience and in particular the impact of
bodily and sexual changes [23].
Limitations
The review only included articles in the English language, and
most of the included studies were carried out in North
America (within a specific healthcare system). As such, it
may limit the understanding of a more global picture of pa-
tients’ experience with BC. The review applied a date limita-
tion from 2000 to present. Although this will have restricted
our search and subsequently missed articles of relevance, it
was an attempt to capture patients’ contemporary experiences
of clinical services and treatments. In synthesising the data
from all the studies, irrespective of their cancer stage and
treatment, subtleties in relation to QoL, need, etc. associated
with certain treatments or extent of illness will have been
missed. Nevertheless, several themes identified in the review
are expected to be common throughout the illness trajectory
and helpful in addressing future care irrespective of stage/
treatment.
Recommendations
The findings of this review are relevant and important to the
field but reflect a paucity of relevant literature. Prior to the
development of any new measure, a clear conceptual frame-
work is needed [39–41], and this review suggests that there are
gaps in our understanding that need to be filled before high-
quality, sensitive measure of QoL can be developed for this
population. This article offers the beginnings of a conceptual
framework (see online resource 3); however, to develop a
robust framework, more research is needed. Future research
J Cancer Surviv
should aim to improve reporting of qualitative findings relat-
ing to BC, should include larger numbers of patients (and
caregivers) receiving non-radical treatments and should in-
clude longitudinal studies to capture change over time. With
this in mind, authors are now undertaking longitudinal sur-
veys into the QoL in patients being treated for and after a
diagnosis of BC, e.g. the OTIS study [http://www.abdn.ac.
uk/hsru/research/assessment/interventional/otis/].
Implications for practice
The review highlights that a better understanding of the pa-
tients’ experience throughout each stage of their pathway
could be gleaned. It is clear that patients’ experience varies
and some require more or less support than others at different
points along the their pathway. Support and informational
needs may be gender specific and may differ in intensity, for
example, for those who may not have support from family
and/or friends.
Conclusion
The findings contribute, through a qualitative synthesis, to a
greater understanding of the lived experience of BC. The re-
view has pooled the evidence making it more accessible to
individual centres where numbers of patients with BC may be
small, thus restricting knowledge of the full effects of cancer
for this group of patients. This might also explain why the
patients’ experience for this group of patients has received less
attention, compared to other cancer types (e.g. breast). It is
noteworthy that these experiences are identified from self-re-
ports, which suggest that discussion of them might be incor-
porated into the clinical pathway when appropriate. The find-
ings identify the impact of BC upon the lived experience and
suggest a need to embed PROMs within care pathways and to
encourage care providers to understand their importance.
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